is mounjaro tirzepatide or semaglutide In adults with obesity but not diabetes, leads to significantly greater weight loss than over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Mounjaro vs Ozempic : Everything

Weight Control: In 2021, Semaglutide gained approval for weight management, particularly in individuals with obesity or overweight with at least one weight-related condition

Sen S, Potnuru PP, Hernandez N, Goehl C, Praestholm C, Sridhar S, et al

Novo Nordisk evaluates that the benefit-risk profile continues to remain favorable." CLICK HERE TO GET THE FOX NEWS APP Dr

With retatrutide, Phase 2 trial data (Jastreboff et al., NEJM , 2023) demonstrated mean reductions in body weight of up to approximately 24% over 48 weeks at the highest dose studied

GFAP-immunoreactive substances were observed in the cell bodies and processes of the astrocytes across astrocytes of the cerebral cortex and cerebellum